Insmed (INSM) EBIT Margin (QoQ) (2011 - 2026)
Powered by 
Analysis
Insmed (INSM) EBIT Margin (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,975.00 |
| Mar 31, 2026 | 7,108.00 |
| Dec 31, 2025 | 13,594.00 |
| Sep 30, 2025 | 3,415.00 |
| Jun 30, 2025 | -2,395.00 |
| Mar 31, 2025 | -4,671.00 |
| Dec 31, 2024 | 784.00 |
| Sep 30, 2024 | 9,135.00 |
| Jun 30, 2024 | -12,707.00 |
| Mar 31, 2024 | 2,029.00 |
| Dec 31, 2023 | -2,626.00 |
| Sep 30, 2023 | 11,822.00 |
| Jun 30, 2023 | -7,779.00 |
| Mar 31, 2023 | 2,825.00 |
| Dec 31, 2022 | -6,690.00 |
| Sep 30, 2022 | -5,313.00 |
| Jun 30, 2022 | 3,374.00 |
| Mar 31, 2022 | 738.00 |
| Dec 31, 2021 | 4,507.00 |
| Sep 30, 2021 | -2,638.00 |